LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Clinical trial NCT00010270 · UNKNOWN

Trial details

NCT number: NCT00010270
Sponsor: University Hospital Freiburg
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Esophageal Cancer Gastric Cancer Pancreatic Cancer

Start date: 2001-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.